Home › Trial NCT06350838
Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)
- Trial IDNCT06350838
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorChengdu CoenBiotech Co., Ltd
- Enrollment10
- Start date2022-11-11
- ConditionsNon-muscular Invasive Bladder Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.